CN104001216B - The CFU-GM of skin-derived is utilized to prepare the method for organization engineering skin - Google Patents
The CFU-GM of skin-derived is utilized to prepare the method for organization engineering skin Download PDFInfo
- Publication number
- CN104001216B CN104001216B CN201410244591.7A CN201410244591A CN104001216B CN 104001216 B CN104001216 B CN 104001216B CN 201410244591 A CN201410244591 A CN 201410244591A CN 104001216 B CN104001216 B CN 104001216B
- Authority
- CN
- China
- Prior art keywords
- skin
- cell
- skps
- organization engineering
- culture medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000008520 organization Effects 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 18
- 239000001963 growth medium Substances 0.000 claims abstract description 19
- 210000001519 tissue Anatomy 0.000 claims abstract description 18
- 239000000515 collagen sponge Substances 0.000 claims abstract description 11
- 230000003321 amplification Effects 0.000 claims abstract description 8
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 8
- 230000005855 radiation Effects 0.000 claims abstract description 7
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 5
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 claims abstract description 3
- 210000003491 skin Anatomy 0.000 claims description 69
- 230000002500 effect on skin Effects 0.000 claims description 8
- 230000029087 digestion Effects 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 210000002615 epidermis Anatomy 0.000 claims description 5
- 102000029816 Collagenase Human genes 0.000 claims description 3
- 108060005980 Collagenase Proteins 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 229960002424 collagenase Drugs 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 108010007093 dispase Proteins 0.000 claims description 3
- 239000000975 dye Substances 0.000 claims description 3
- 239000007850 fluorescent dye Substances 0.000 claims description 3
- 230000012447 hatching Effects 0.000 claims description 3
- 238000005213 imbibition Methods 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 206010033675 panniculitis Diseases 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 238000009288 screen filtration Methods 0.000 claims description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 abstract description 58
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract description 10
- 230000035876 healing Effects 0.000 abstract description 9
- 210000004204 blood vessel Anatomy 0.000 abstract description 8
- 238000000926 separation method Methods 0.000 abstract description 3
- 210000003556 vascular endothelial cell Anatomy 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 description 46
- 206010052428 Wound Diseases 0.000 description 45
- 229920001436 collagen Polymers 0.000 description 33
- 102000008186 Collagen Human genes 0.000 description 26
- 108010035532 Collagen Proteins 0.000 description 26
- 102000008730 Nestin Human genes 0.000 description 15
- 108010088225 Nestin Proteins 0.000 description 15
- 210000005055 nestin Anatomy 0.000 description 15
- 238000002372 labelling Methods 0.000 description 11
- 230000029663 wound healing Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 230000004069 differentiation Effects 0.000 description 7
- 206010063560 Excessive granulation tissue Diseases 0.000 description 6
- 210000001126 granulation tissue Anatomy 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 208000028990 Skin injury Diseases 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 210000003725 endotheliocyte Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 230000010388 wound contraction Effects 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010072170 Skin wound Diseases 0.000 description 3
- 102000004243 Tubulin Human genes 0.000 description 3
- 108090000704 Tubulin Proteins 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000010166 immunofluorescence Methods 0.000 description 3
- 239000002932 luster Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000002491 angiogenic effect Effects 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003716 mesoderm Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 210000005155 neural progenitor cell Anatomy 0.000 description 2
- 230000003076 paracrine Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 2
- 208000008960 Diabetic foot Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 1
- 101000713275 Homo sapiens Solute carrier family 22 member 3 Proteins 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001421714 Olynthus Species 0.000 description 1
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
- 101710088580 Stromal cell-derived factor 1 Proteins 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000933 neural crest Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of method utilizing the CFU-GM of skin-derived to prepare organization engineering skin, the method comprises the following steps: 1) be separated SKPs; 2) separation is obtained? SKPs moves in amplification culture medium and increases; 3) the DiI fluorochrome label of SKPs; 4) prepare organization engineering skin, collagen sponge card punch is made diameter 8mm circular collagen sponge Co60 radiation sterilization, SKPs cell 1 × 105/20-30uL culture medium is added on sponge exasperate, cultivates.SKPs in organization engineering skin of the present invention can be divided into smooth muscle cell, vascular endothelial cell, nervous tissue, the smooth muscle cell differentiated, vascular endothelial cell can participate in forming blood vessel structure, promote that wound new vessels is formed, thus improve skin healing speed and healing quality.
Description
Technical field
The present invention relates to organization engineering skin preparing technical field, especially relate to a kind of method utilizing the CFU-GM of skin-derived to prepare organization engineering skin.
Background technology
Refractory Diabetic skin injury (as: diabetic foot) is one of common chronic complicating diseases of diabetes, is that diabetics is disabled, lethal main cause.Its high incidence, high disability rate, difficult therapeutic, high medical expense etc., make the quality of life degradation of diabetics, bring heavy financial burden to patient and society.The routine clinical treatment means of Refractory Diabetic skin injury comprises control blood glucose, improve the nutriture of patient, improve local blood supply, infection, promotes peripheroneural functional rehabilitation, intensive care, debridement, skin grafting etc., but therapeutic effect is usually not good enough, and current treatment emphasis is still avoids amputation.Therefore more efficiently Therapeutic Method must be found.
At present, tissue engineering skin has become a kind of more perfect engineered tissue, and Preliminary Applications is in clinical, reparation for skin injury provides new method, but still there are problems, as: there is not the component of organization such as blood vessel, melanocyte, skin appendages structure can not be rebuild, mechanical performance with normally have larger gap etc. at body skin.
Stem cell is the cell that a class has self replication and multi-lineage potential, has the potential being divided into Various Tissues type.In recent years, stem cell has become new study hotspot as seed cell treatment Refractory Diabetic skin lesion.Research proves, ESC and MSC all can produce the composed component of skin histology, thus participates in the repair process of skin trauma, and this feature can make up the defect of engineered skin substitute, improves repair ability and the healing quality of skin.But the existence of the problems such as the carcinogenic possibility existed after the relevant ethics morals problem caused owing to using above-mentioned cell, transplanting, cell derived is not enough, make clinical practice greatly limited, we need to find new seed cell to avoid the problems referred to above.
Calendar year 2001, Tomaetal., from the dermal layer of the skin taking from rodent newborn individual and adult, is separated the CFU-GM (skin-derivedprecursors, SKPs) obtaining skin-derived.Multinomial research in recent years shows, SKPs is a kind of multipotency CFU-GM of novel, neural crest, is present in mammal skin corium, in vitro in experiment, finally can produce nerveous system filial generation and mesoderm filial generation.At present, the cell with SKPs character has also been separated and has obtained from all ages and classes and the human skin of origin, routine can also obtain from human foreskin.Because SKPs has multipotency, no matter when normal physiological renewal or injury repairing, the mesoderm composition participating in forming dermal layer of the skin all may be broken up, comprises dermal fibroblast, vascular smooth muscle cell etc.There are some researches show, SKPs can be divided into vascular smooth muscle cell, also may have the ability forming endotheliocyte.
After using existing SKPs to be applied to skin wound, vascular smooth muscle and endotheliocyte can be divided into, thus promote that wound new vessels is formed, wound healing.But its healing rate is still comparatively slow, effect is still not ideal enough.How to find one and can promote that wound new vessels is formed in a large number fast, promote that the method for wound surface quickly-healing has become current problem demanding prompt solution, wound surface quickly-healing damages the clinical practice for the treatment of to diabetic skin and has great significance, and the clinical treatment that also can be the chronic wound surface in refractory to treatment of DM brings very big help.
Summary of the invention
Instant invention overcomes shortcoming of the prior art, provide one and can promote that wound new vessels is formed in a large number fast, promote that the CFU-GM of skin-derived that utilizes of wound surface quickly-healing prepares the method for organization engineering skin.
In order to solve the problems of the technologies described above, the present invention is achieved by the following technical solutions: a kind of method utilizing the CFU-GM of skin-derived to prepare organization engineering skin, comprises the following steps:
1), SKPs is separated
Skin samples is put into aseptic PB, is separated and discards subcutaneous tissue under microscope, epidermis and dermal tissue are cut into small pieces and put into dispase enzyme, 4 DEG C of digestion are spent the night; Within second day, take out, be separated and discard skin portion, retain skin corium tissue; Add collagenase 37 DEG C digestion 1h; Piping and druming is organized until unicellular, with 40um aperture cell screen filtration cell; Unicellular with complete culture medium culturing, changed liquid once every seven days;
2), SKPs rapid amplifying
Carry out passage when cell forms clone ball and shade in centre, go down to posterity in the ratio of 1:2, amplification cultivation in amplification culture medium;
3), the DiI fluorochrome label of SKPs
After hatching 5min in cell suspension 37 DEG C of incubators, be that 3ug/mlDiI fluorescent dye hatches 8min with middle concentration; Wash 3 times with PBS afterwards, remove excess dyestuff, be resuspended in normal saline, cell counting is for subsequent use, 4 DEG C, cell preservation before transplanting;
4), organization engineering skin is prepared
The circular collagen sponge of diameter 8mm made by collagen sponge pretreatment card punch, puts into o.o1MPBS, aerofluxus; Co60 radiation sterilization, irradiation dose 20K; Bed board in super-clean bench, ultra-vioket radiation 0.5h; Every hole 300ul culture medium, spends the night in 37 DEG C of incubators; Sponge is transferred in another orifice plate; Cell 1 × 105/20-30uL culture medium is added on sponge exasperate; 4h is hatched, cell attachment in 37 DEG C of incubators; After 4h, culture medium 200-300uL/ hole adds, and hatches in 37 DEG C of incubators; After 1 day, change liquid once, from the imbibition of sponge edge, inoculating cell was transplanted after 3 days.
Preferably, described skin samples is epidermis and dermal tissue.
Preferably, described skin samples is newborn C57 neonatal rat skin of back.
Preferably, wherein said step 1) condition of culture be cultivate in 37 DEG C of incubators.
Preferably, wherein said step 2) in, described amplification culture medium is complete medium; Condition of culture is 37 DEG C of incubators.
Preferably, wherein said step 4) in, described bed board mode is 48 orifice plates, exasperate upwards, exasperate upper berth cell.
Compared with prior art, tool of the present invention has the following advantages: organization engineering skin of the present invention promotes that the quantity of angiogenic growth is 2.95 times of control group, be 1.68 times of collagen group, it can promote that wound new vessels is formed in a large number fast, promotes wound surface quickly-healing.It is the effective means that diabetic skin damage is carried out treating, and is the optimum selection of the clinical treatment of the chronic wound surface in refractory to treatment of DM.
Accompanying drawing explanation
In order to be illustrated more clearly in the embodiment of the present invention or technical scheme of the prior art, be briefly described to the accompanying drawing used required in embodiment or description of the prior art below, apparently, accompanying drawing in the following describes is only some embodiments of the present invention, for those of ordinary skill in the art, under the prerequisite not paying creative work, other accompanying drawing can also be obtained according to these accompanying drawings.
Fig. 1 is the organization engineering skin that the present invention prepares;
Fig. 2 is the comparison chart that the present invention tests 1 each experimental group wound healing;
Fig. 3 is the shrinkage factor figure of each test group wound adopting IPP6.0 image analysis software to calculate:
Wound healing figure when Fig. 4 is each test group of Microscopic observation 7 days;
Wound healing figure when Fig. 5 is each test group of Microscopic observation 14 days;
Fig. 6 is skps+collagen group Nestin immunofluorescence SKPs survival colored graph;
Fig. 7 is skps+collagen group vWF new vessels colored graph;
Fig. 8 is skps+collagen group SMA smooth muscle cell colored graph;
Fig. 9 is skps+collagen group tubulin neurocyte colored graph;
Figure 10 is skps+collagen group SMA+nestin new vessels and smooth muscle cell colored graph;
Figure 11 is skps+collagen group vWF+nestin new vessels colored graph;
SMA new vessels colored graph when Figure 12 is each processed group 14 days.
Detailed description of the invention
Below in conjunction with the accompanying drawing in the embodiment of the present invention, be clearly and completely described the technical scheme in the embodiment of the present invention, obviously, described embodiment is only the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not paying the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
Embodiment 1:
1, isolation identification, the labelling of SKPs
The newborn C57 neonatal rat neck that breaks is put to death, and back unhairing, cuts skin of back, puts into aseptic PBS.
Be separated under Stereo microscope and discard subcutaneous tissue, epidermis and dermal tissue being cut into small pieces and putting into dispase enzyme, 4 DEG C of digestion are spent the night; Within second day, take out, be separated and discard skin portion, retain skin corium tissue; Add collagenase 37 DEG C digestion 1h; Piping and druming is organized until unicellular, with 40um aperture cell screen filtration cell; Unicellular with complete culture medium culturing, changed liquid once every seven days, the condition of culture of this step is cultivate in 37 DEG C of incubators.
2, SKPs rapid amplifying
Carry out passage when cell forms clone ball and shade in centre, go down to posterity in the ratio of 1:2, carry out in complete medium; Condition of culture is 37 DEG C of incubators.
3, the labelling of SKPs
After hatching 5min in cell suspension 37 DEG C of incubators, be that 3ug/mlDiI fluorescent dye hatches 8min with final concentration.Wash 3 times with PBS afterwards, remove excess dyestuff, be resuspended in normal saline, cell counting is for subsequent use, 4 DEG C, cell preservation before transplanting.
4, organization engineering skin is prepared
(1) collagen sponge pretreatment
A, size: the circular collagen sponge of diameter 8mm made by card punch, puts into o.o1MPBS, aerofluxus;
B, Co60 radiation sterilization, irradiation dose 20K, (Tianjin physics Institute).
(2) collagen sponge bed board
Bed board in a, super-clean bench (48 orifice plates, exasperate upwards, exasperate upper berth cell) ultra-vioket radiation 0.5h;
B, every hole 300ul culture medium, spend the night in 37 DEG C of incubators.
(3) collagen sponge paving cell
A, sponge is transferred in another 48 orifice plate;
B, cell 1 × 105/20-30uL culture medium are added on sponge exasperate;
4h is hatched, cell attachment in c, 37 DEG C of incubators;
After d, 4h, culture medium 200-300uL/ hole adds, and hatches in 37 DEG C of incubators;
E, after 1 day, change liquid once, from the imbibition of sponge edge, interference cell is not adherent as far as possible;
F, inoculating cell were transplanted after 3 days, and organization engineering skin is shown in Fig. 1.
The making process of composition engineering skin sample
1, light rinsing: soft rinsing Combined culture thing 2--3min × 3 time in the PBS of 37 DEG C of preheatings.
2, fixing
2h in (1) 2.5% glutaraldehyde 37 DEG C incubator.
(2), after changing 2.5% glutaraldehyde, in 2.5% glutaraldehyde, 4 DEG C are spent the night.
3, gradient alcohol dehydration
4, after naturally drying 4h, evacuation 2h.For subsequent use.
To quantity and the active observation (mtt assay) of survivaling cell in the organization engineering skin of embodiment 1 preparation
1,5mg/mlMTT25ul adds in Combined culture thing respectively, and 37 DEG C of incubators hatch 4h.
2, develop the color: pipettor siphons away supernatant, and being cut by sponge with sterilizing scissors is 4 lobes, and every hole lucifuge adds 300ulDMSO, beats gently with pipettor.Agitator shakes 15min, omnidistance attention lucifuge.
3, colorimetric: every hole is got 50ul and is transferred in 96 new orifice plates, surveys OD value (wavelength: 490nm).
4, each time point (after transplanting 1,3,5 day) is surveyed 3 times respectively, often organizes survey three samples at every turn, averages.
Expert's conclusion
1, the separation of cell.The method of Tomaetal. has been used for reference in this experiment, skin is digested to unicellular after, use serum-free medium cultivate.Separation efficiency is very high, maintains the CFU-GM state of cell.By document comparison, can prove, great majority plant the isolated cell of method therewith about the isolated nestin positive cell of hair follicle stem cells document is instantly homologous cell, all from neural ridge.
2, cell amplification in vitro and go down to posterity.This cell increasess slowly under the condition of serum-free, fully maintains its CFU-GM feature.After cell adds the culture medium of variable concentrations serum, its corresponding increase of rising in value, differentiation also corresponding beginning.
3, the differentiation qualification of cell.In the growth course of cell, remove somatomedin, and add serum, cell can carry out multidirectional differentiation, as nerve, fat, smooth muscle etc., differentiation efficiency is different according to different differentiation directions from the time, and the easiest differentiation direction of hair follicle stem cells is smooth muscle cell and neurocyte.
4, the qualification work of cell progenitors and paracrine ability has been carried out.This cellular expression nestin, this is the labelling of neural progenitor cell, and nanog and OCT3/4 is the labelling of embryonic stem cell, and the expression of SDF-1 and bFGF proves that it has the ability of paracrine.
The foundation of test 1:C57 mice T2DM skin injury model
(1) anaesthetize: 4% chloral hydrate 350mg/kg lumbar injection is in C57 mice T2DM model.
(2) preserved skin, fixing, sterilization: remove mouse back Mus hair, the outside of belly is fixed on downwards in surgical console, and skin of back is sterilized.
(3) set up skin lesion model: on mouse back median line, cut with operating scissors the circular skin injury that a diameter is 8mm, lesion thickness reaches skin holostrome, front and back each.
(4) transplant: arrange three groups of migration process groups, each processed group gives different disposal.Control group: normal healing; Collagen group: transplant collagen sponge; Skps-collagen group: transplant organization engineering skin of the present invention.
(5) fixing sponge: with 7/0 suturing with thread management fixing glue olynthus in mouse skin wound place.Notice that sponge and wound expose organize well involutory.
(6) postoperative: Sterilized application covers.The single cage of all mices is fed, and ad lib high-sugar-fat-diet, freely drinks water.
Test the result of 1 wound repair
1, wound healing general appearance
Whole wound all without infection, wound is shunk to wound center gradually by wound edge, Fig. 2 illustrate control group, collagen group and collagen+skps group 0 day, 7 days and 14 days time wound healing state.
1) control group: wound surface contraction of skin is slow, crust is belittled, granulation tissue poor growth under crust, and color and luster is dark red, and matter is crisp, and very easily damaged under external force, healing quality is poor.Hinder latter 14 days, wound surface heals substantially, and comparatively obvious by skin healing cicatrix, crust obviously remains.
2) collagen group: wound surface contraction of skin is fast, and visible thin layer granulation tissue under crust, color and luster is dark red.Hinder latter 14 days, wound surface heals substantially, leaves a small amount of crust.
3) collagen+skps group: wound surface contraction of skin is fast, under crust, granulation tissue growth is comparatively firm, and color and luster is more ruddy, and wound surface is dry, and neoplastic skin is smooth, and skin healing cicatrix is obviously less.Hinder latter 14 days, wound healing, part crust comes off completely.
2, speed of wound healing
Perusal: transplant in 7 days, collagen, skps-collagen group wound contraction is all faster than control group.
(Fig. 3) is calculated through IPP6.0 image analysis software, when transplanting latter 7 days, each group of wound contraction rate has notable difference (p < 0.01), wound contraction rate when 7 days: skps-collagen group > collagen group > control group.When 14 days, each group wound contraction rate zero difference, wound is all substantially closed.
3, Microscopic observation wound healing quality (× 100 times of visual field picture mosaics)
When 7 days (Fig. 4), wound granulation tissue is formed, epithelium by wound edge to wound central authorities hypertrophy, bottom wound and a large amount of new vessels of wound edge formed; The visible granulation tissue of control group is formed poor, and bottom wound, new vessels is formed.Compared with control group, collagen group and collagen+skps form mouth place cambium and are formed more plentiful, and granulation tissue is formed good, bottom wound and the visible a large amount of new vessels of window edge formed, inflammatory cell invades profit, and organizational structure is more complete.
When 14 days (Fig. 5), respectively form a mouthful cambium structural integrity.By contrast, control group granulation is formed slowly, and structure is belittled, poor structural integrity.
4, organization engineering skin of the present invention is to smooth muscle, endothelium, Neural Differentiation, promotes that new vessels is formed and analyzes;
Skps+collagen group Nestin immunofluorescence SKPs survival colored graph (Fig. 6): skps+collagen group immunofluorescence dyeing when 7 days, bottom wound and the visible DiI positive cell of wound edge overlap with nestin positive cell, the SKPs survival that there is transplanted cells source is described in tissue, and maintains the labelling of neural progenitor cell.
Skps+collagen group vWF new vessels colored graph (Fig. 7): bottom wound and wound edge DiI positive cell overlap with vWF positive cell.The cell survival existing in tissue and transplant SKPs source is described, and expresses the labelling of endotheliocyte.The SKPs of provable transplanting is divided into endotheliocyte, take part in the formation of new vessels, participates in tissue repair.
Skps+collagen group SMA smooth muscle cell colored graph (Fig. 8): bottom wound and wound edge DiI positive cell SMA positive cell overlap.The cell survival existing in tissue and transplant SKPs source is described, and expresses the labelling of smooth muscle cell, participate in forming tubular structure.The SKPs of provable transplanting is divided into smooth muscle cell, take part in the formation of new vessels, participates in tissue repair.
Skps+collagen group tubulin neurocyte colored graph (Fig. 9): wound edge is easily shown in that DiI positive cell overlaps with tubulin positive cell.The cell survival existing in tissue and transplant SKPs source is described, and expresses the labelling of neurocyte.The SKPs of provable transplanting is divided into nervous tissue, take part in the formation of newborn nervous tissue.
Skps+collagen group SMA+nestin new vessels and smooth muscle cell colored graph (Figure 10): bottom wound and wound edge easily see that nestin positive cell overlaps with SMA positive cell, nestin is one of SKPs labelling, nestin positive cell expresses smooth muscle cell labelling, take part in the formation of new vessels.
Skps+collagen group vWF+nestin new vessels colored graph (Figure 11): bottom wound and wound edge easily see that nestin positive cell overlaps with vWF positive cell, nestin is one of SKPs labelling, nestin positive cell expresses endothelial cell marker, take part in the formation of new vessels.
5, damage zone blood vessel number calculates
According to SMA coloration result (Figure 12), counting is transplanted after latter 14 days, blood vessel number in wound area.Result: skps-collagen group blood vessel number, more than control group, has statistical significance (p < 0.05).Blood vessel number in wound area: skps-collagen group > collagen group > control group.Skps-collagen combined transplantation facilitates new vessels and is formed, thus promotes skin wounds healing, and each test group blood vessel number sees the following form.
| Grouping | control | collagen | skps-collagen |
| 14 days blood vessel number | 21.07±4.99 | 39.82±0.14 | 62.07±0.11 |
Testing surface, organization engineering skin of the present invention promotes that the quantity of angiogenic growth is 2.95 times of control group, and be 1.68 times of collagen group, it can promote that wound new vessels is formed in a large number fast, promotes wound surface quickly-healing.It is the effective means that diabetic skin damage is carried out treating, and is the optimum selection of the clinical treatment of the chronic wound surface in refractory to treatment of DM.
The foregoing is only preferred embodiment of the present invention, not in order to limit the present invention, within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (5)
1. utilize the CFU-GM of skin-derived to prepare a method for organization engineering skin, comprise the following steps:
1), SKPs is separated
Skin samples is put into aseptic PBS, is separated and discards subcutaneous tissue under microscope, epidermis and dermal tissue are cut into small pieces and put into dispase enzyme, 4 DEG C of digestion are spent the night; Within second day, take out, be separated and discard skin portion, retain skin corium tissue; Add collagenase 37 DEG C digestion 1h; Piping and druming is organized until unicellular, with 40um aperture cell screen filtration cell; Unicellular with complete culture medium culturing, changed liquid once every seven days;
2), SKPs rapid amplifying
Carry out passage when cell forms clone ball and shade in centre, go down to posterity in the ratio of 1:2, amplification cultivation in amplification culture medium;
3), the DiI fluorochrome label of SKPs
After hatching 5min in cell suspension 37 DEG C of incubators, be that 3ug/mlDiI fluorescent dye hatches 8min with middle concentration; Wash 3 times with PBS afterwards, remove excess dyestuff, be resuspended in normal saline, cell counting is for subsequent use, 4 DEG C, cell preservation before transplanting;
4), organization engineering skin is prepared
The circular collagen sponge of diameter 8mm made by collagen sponge pretreatment card punch, puts into 0.01MPBS, aerofluxus; Co60 radiation sterilization, irradiation dose 20K; Bed board in super-clean bench, ultra-vioket radiation 0.5h; Every hole 300ul culture medium, spends the night in 37 DEG C of incubators; Sponge is transferred in another orifice plate; Cell 1 × 105/20-30uL culture medium is added on sponge exasperate; 4h is hatched, cell attachment in 37 DEG C of incubators; After 4h, culture medium 200-300uL/ hole adds, and hatches in 37 DEG C of incubators; After 1 day, change liquid once, from the imbibition of sponge edge, inoculating cell was transplanted after 3 days;
Step 1) described in skin samples be epidermis and dermal tissue.
2. a kind of method utilizing the CFU-GM of skin-derived to prepare organization engineering skin as claimed in claim 1, is characterized in that described skin samples is newborn C57 neonatal rat skin of back.
3. a kind of method utilizing the CFU-GM of skin-derived to prepare organization engineering skin as claimed in claim 1, is characterized in that step 1) described in condition of culture be cultivate in 37 DEG C of incubators.
4. a kind of method utilizing the CFU-GM of skin-derived to prepare organization engineering skin as claimed in claim 1, is characterized in that step 2) in, described amplification culture medium is complete medium; Condition of culture is 37 DEG C of incubators.
5. a kind of method utilizing the CFU-GM of skin-derived to prepare organization engineering skin as claimed in claim 1, is characterized in that step 4) in, described bed board mode is 48 orifice plates, exasperate upwards, exasperate upper berth cell.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410244591.7A CN104001216B (en) | 2014-06-04 | 2014-06-04 | The CFU-GM of skin-derived is utilized to prepare the method for organization engineering skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410244591.7A CN104001216B (en) | 2014-06-04 | 2014-06-04 | The CFU-GM of skin-derived is utilized to prepare the method for organization engineering skin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104001216A CN104001216A (en) | 2014-08-27 |
| CN104001216B true CN104001216B (en) | 2016-01-27 |
Family
ID=51362297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410244591.7A Expired - Fee Related CN104001216B (en) | 2014-06-04 | 2014-06-04 | The CFU-GM of skin-derived is utilized to prepare the method for organization engineering skin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104001216B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106987557A (en) * | 2017-05-18 | 2017-07-28 | 四川大学华西医院 | Improved method for culturing human skin pluripotent stem cells (SKPs) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1563366A (en) * | 2004-04-09 | 2005-01-12 | 西北农林科技大学 | Preparation method and application of epidermal stem cell constructed tissue engineering corneal epithelial implant |
| DE102008017990A1 (en) * | 2007-02-07 | 2009-10-08 | Dagmar Briechle | Method for producing dendritic cell-like cells and use of these cells in in-vitro test methods for determining the influence of exogenous substances |
| CN102462864A (en) * | 2010-11-12 | 2012-05-23 | 中国辐射防护研究院 | Novel method for constructing tissue engineering skin |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5905446B2 (en) * | 2010-03-24 | 2016-04-20 | ライフネット ヘルス | BMP-4 peptide and method of use |
-
2014
- 2014-06-04 CN CN201410244591.7A patent/CN104001216B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1563366A (en) * | 2004-04-09 | 2005-01-12 | 西北农林科技大学 | Preparation method and application of epidermal stem cell constructed tissue engineering corneal epithelial implant |
| DE102008017990A1 (en) * | 2007-02-07 | 2009-10-08 | Dagmar Briechle | Method for producing dendritic cell-like cells and use of these cells in in-vitro test methods for determining the influence of exogenous substances |
| CN102462864A (en) * | 2010-11-12 | 2012-05-23 | 中国辐射防护研究院 | Novel method for constructing tissue engineering skin |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104001216A (en) | 2014-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103785064B (en) | Human skin module and application thereof | |
| CN103356701B (en) | Pharmaceutical composition for cell therapy of pigmentation disorders | |
| JP6309268B2 (en) | Dosage unit formulation of autologous dermal fibroblasts | |
| Huyan et al. | Pilot study of the biological properties and vascularization of 3D printed bilayer skin grafts | |
| CN101856517B (en) | Tissue engineering material-based culture method and applications of melanophore | |
| CN102690344A (en) | Application of pigment epithelium derived factor derived polypeptide in promoting stem cell proliferation and wound healing | |
| CN104548209B (en) | Tissue-engineered epidermis and preparation method thereof | |
| CN101347640A (en) | Analogue model of skin with pigments for selecting stripping agent and construction method thereof | |
| CN105132358B (en) | Method for obtaining tissue engineering epidermis by culture and application thereof | |
| Ferretti et al. | Angiogenesis and nerve regeneration in a model of human skin equivalent transplant | |
| CN105176914A (en) | Simultaneous autologous epidermic cell and fibrocyte preparation method and biological cosmetic product thereof | |
| CN105820998A (en) | Isolation extraction and culture method for human adipose-derived stem cells (ADSCs) for clinical back-transfusion grade cell therapy | |
| CN108057116A (en) | Application of the stem cell composition in skin injury medicine | |
| CN104667352B (en) | A kind of preparation method of the tissue engineering epidermis with hypodermal cell | |
| CN104611289A (en) | Method for simultaneously preparing autologous epidermal cells and fibroblasts, and biological beauty product comprising autologous epidermal cells and fibroblasts | |
| Jiang et al. | Nerve defect repair by differentiated adipose-derived stem cells and chondroitinase ABC-treated acellular nerves | |
| CN103550828A (en) | Skin renewal method based on hair follicle stem cells and silica gel dressing | |
| CN104001216B (en) | The CFU-GM of skin-derived is utilized to prepare the method for organization engineering skin | |
| CN108066750A (en) | Stem cell and its secretion are used to treat the new application of skin burn | |
| CN104399122B (en) | A kind of acellular matrix and preparation method thereof | |
| CN108486046A (en) | A kind of stem cell medicine of anti anoxia damage and preparation method thereof with preparing the application in treating acute myocardial infarction drug | |
| CN1289156C (en) | Tissue engineering autologous cornea epithelium and its preparation method | |
| CN108066824A (en) | A kind of new method for preparing skin blemish medicine | |
| CN105925524A (en) | Method for transforming human primary fibroblast into epidermic cell | |
| CN112522180B (en) | Human scalp hair follicle single cell suspension and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160127 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |